Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Major
|MRK||Merck & Co., Inc.||0.11%||82.36||0.7%||$1556.69m|
|JNJ||Johnson & Johnson||-0.04%||165.70||0.7%||$1044.17m|
|LLY||Eli Lilly & Co.||0.43%||249.55||1.1%||$641.87m|
|BMY||Bristol-Myers Squibb Co.||-0.16%||58.12||1.0%||$633.95m|
|AVIR||Atea Pharmaceuticals, Inc.||0.00%||12.39||0.3%||$123.47m|
|NVO||Novo Nordisk A/S||-1.31%||105.97||0.1%||$89.66m|
|OGN||Organon & Co.||-0.33%||36.62||0.0%||$52.99m|
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.